Skip to main content

Read the latest news about research and scientific resultats on Alzheimer's disease at the Barcelonaβeta Brain Research Center (BBRC).

19 Oct | 2021

Identified in the blood a biomarker that allows to detect in a very precise way the initial phases of the Alzheimer’s disease

Researchers at the Pasqual Maragall Foundation's research center, the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation, have detected that the glial fibrillar acid protein (GFAP) is a very accurate biomarker for diagnosing in blood the early stages of Alzheimer’s disease. 

23 Jul | 2021

The project on artificial intelligence algorithms in magnetic resonance obtains a 'Digital EIT 2021'

The organization under the European Commission will finance part of the project

15 Jul | 2021

"A titanic effort is being made to understand Alzheimer's disease in its early stages"

Interview with Gemma Salvadó, researcher of the Neuroimaging Group, after obtaining her PhD

13 Jul | 2021

Identified a new association between light neurofilaments and other markers of Alzheimer's disease

Researchers at the Barcelonaβeta Brain Research Center (BBRC) have identified that people with amyloid pathology and subjective cognitive impairment have an increase in light neurofilaments (NfL) in the cerebrospinal fluid and a lower volume in the hippocampus.

16 Jun | 2021

Weight loss may be an indicator of an increased risk of developing Alzheimer's disease

A study led by the BBRC, with the support of the “la Caixa” Foundation, suggests that people at increased risk of developing Alzheimer's experience weight loss that would precede cognitive impairment.

14 Jun | 2021

The United States approves the commercialization of a drug that could slow down Alzheimer's disease

The last drug approved by the FDA was in 2003, and until now any treatment has proved to slow down the progression of the disease.

06 Apr | 2021

BBRC researchers discovered new benefits of blue fish consumption in people at risk of developing Alzheimer's disease

A study led by the BBRC has found that people without cognitive problems but with a higher genetic risk of developing Alzheimer's have certain areas of the brain more resilient to the disease if they are accustomed to consuming a nutrient provided by blue fish.

11 Mar | 2021

European researchers improve the sensitivity to detect the early stages of Alzheimer's disease

A team of researchers from the AMYPAD consortium, led at BBRC, showed that the visual assessment used in clinical practice to evaluate amyloid PET images is sensitive to detecting the earliest stages of Alzheimer’s disease, and suggests a method to classify the extent of the pathology in the brain.

16 Feb | 2021

Spanish scientists uncover early links between cardiovascular risk and brain metabolism

Investigators at the CNIC, in partnership with the BBRC, have discovered a link between brain metabolism, cardiovascular risk, and atherosclerosis during middle age, years before symptoms appear